Methods Mentioned
BETA
ESR
biopsy
flow cytometry
biopsies
PCR
Related Concepts
Related Feeds
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Related Papers
Mayo Clinic Proceedings
C R SchadG W Dewald
Leukemia Research
Jin Yeong HanJae-Seok Kim
The Korean journal of laboratory medicine
Kyong Eun KimJin Yeong Han
Journal of the National Comprehensive Cancer Network : JNCCN
C Cameron YinCarlos E Bueso-Ramos
Cancer Genetics
Jason KoshyPeter Papenhausen